Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary Antibodies

Immunostaining is a powerful technique and widely used to identify molecules in tissues and cells, although critical steps are necessary to block cross-reaction. Here we focused on an overlooked cross immunoreactivity issue where a secondary antibody (secondary) cross-reacts with a primary antibody...

Full description

Bibliographic Details
Main Authors: Shanping Mao, Guoxiang Xiong, Brian N. Johnson, Noam A. Cohen, Akiva S. Cohen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.579859/full
id doaj-460413ad9f0b49cd96f359ad1c701dc0
record_format Article
spelling doaj-460413ad9f0b49cd96f359ad1c701dc02021-05-25T05:00:48ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-05-011510.3389/fnins.2021.579859579859Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary AntibodiesShanping Mao0Guoxiang Xiong1Brian N. Johnson2Noam A. Cohen3Noam A. Cohen4Akiva S. Cohen5Akiva S. Cohen6Department of Neurology, Renmin Hospital, Wuhan University, Wuhan, ChinaDepartment of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesPhiladelphia Veterans Affairs Medical Center, Philadelphia, PA, United StatesDepartments of Otorhinolaryngology—Head and Neck Surgery, Perelman School of Medicine, University of Pennslyvania, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDepartment of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United StatesImmunostaining is a powerful technique and widely used to identify molecules in tissues and cells, although critical steps are necessary to block cross-reaction. Here we focused on an overlooked cross immunoreactivity issue where a secondary antibody (secondary) cross-reacts with a primary antibody (primary) from a different species. We first confirmed the previously reported cross-species binding of goat anti-mouse secondary to rat primary. This was accomplished by staining with a rat primary against glial fibrillary acidic protein (GFAP) and visualizing with goat (or donkey) anti-mouse secondary. We then further revealed the converse cross-species binding by staining with a mouse primary against neuronal nuclear protein (NeuN) and visualizing with anti-rat secondaries. We speculate that mouse and rat primaries share antigenicity, enabling either secondary to recognize either primary. To block this cross-species binding in double staining experiments, we compared three protocols using mouse anti-NeuN and rat anti-GFAP, two primaries whose antigens have non-overlapping distributions in brain tissues. Simultaneous staining resulted in cross-species astrocytic staining (anti-mouse secondary to rat anti-GFAP primary) but no cross-species neuronal staining (anti-rat secondary to mouse anti-NeuN primary). Cross-species astrocytic staining was missing after sequential same-species staining with mouse anti-NeuN primary, followed by rat anti-GFAP. However, cross-species astrocytic staining could not be diminished after sequential same-species staining with rat anti-GFAP primary, followed by mouse anti-NeuN. We thus hypothesize that a competition exists between anti-mouse and anti-rat secondaries in their binding to both primaries. Single staining for NeuN or GFAP visualized with dual secondaries at different dilution ratio supported this hypothesis.https://www.frontiersin.org/articles/10.3389/fnins.2021.579859/fullcross immunoreactivityimmunohistochemistryfluorescent stainingrodentguinea pig
collection DOAJ
language English
format Article
sources DOAJ
author Shanping Mao
Guoxiang Xiong
Brian N. Johnson
Noam A. Cohen
Noam A. Cohen
Akiva S. Cohen
Akiva S. Cohen
spellingShingle Shanping Mao
Guoxiang Xiong
Brian N. Johnson
Noam A. Cohen
Noam A. Cohen
Akiva S. Cohen
Akiva S. Cohen
Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary Antibodies
Frontiers in Neuroscience
cross immunoreactivity
immunohistochemistry
fluorescent staining
rodent
guinea pig
author_facet Shanping Mao
Guoxiang Xiong
Brian N. Johnson
Noam A. Cohen
Noam A. Cohen
Akiva S. Cohen
Akiva S. Cohen
author_sort Shanping Mao
title Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary Antibodies
title_short Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary Antibodies
title_full Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary Antibodies
title_fullStr Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary Antibodies
title_full_unstemmed Blocking Cross-Species Secondary Binding When Performing Double Immunostaining With Mouse and Rat Primary Antibodies
title_sort blocking cross-species secondary binding when performing double immunostaining with mouse and rat primary antibodies
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2021-05-01
description Immunostaining is a powerful technique and widely used to identify molecules in tissues and cells, although critical steps are necessary to block cross-reaction. Here we focused on an overlooked cross immunoreactivity issue where a secondary antibody (secondary) cross-reacts with a primary antibody (primary) from a different species. We first confirmed the previously reported cross-species binding of goat anti-mouse secondary to rat primary. This was accomplished by staining with a rat primary against glial fibrillary acidic protein (GFAP) and visualizing with goat (or donkey) anti-mouse secondary. We then further revealed the converse cross-species binding by staining with a mouse primary against neuronal nuclear protein (NeuN) and visualizing with anti-rat secondaries. We speculate that mouse and rat primaries share antigenicity, enabling either secondary to recognize either primary. To block this cross-species binding in double staining experiments, we compared three protocols using mouse anti-NeuN and rat anti-GFAP, two primaries whose antigens have non-overlapping distributions in brain tissues. Simultaneous staining resulted in cross-species astrocytic staining (anti-mouse secondary to rat anti-GFAP primary) but no cross-species neuronal staining (anti-rat secondary to mouse anti-NeuN primary). Cross-species astrocytic staining was missing after sequential same-species staining with mouse anti-NeuN primary, followed by rat anti-GFAP. However, cross-species astrocytic staining could not be diminished after sequential same-species staining with rat anti-GFAP primary, followed by mouse anti-NeuN. We thus hypothesize that a competition exists between anti-mouse and anti-rat secondaries in their binding to both primaries. Single staining for NeuN or GFAP visualized with dual secondaries at different dilution ratio supported this hypothesis.
topic cross immunoreactivity
immunohistochemistry
fluorescent staining
rodent
guinea pig
url https://www.frontiersin.org/articles/10.3389/fnins.2021.579859/full
work_keys_str_mv AT shanpingmao blockingcrossspeciessecondarybindingwhenperformingdoubleimmunostainingwithmouseandratprimaryantibodies
AT guoxiangxiong blockingcrossspeciessecondarybindingwhenperformingdoubleimmunostainingwithmouseandratprimaryantibodies
AT briannjohnson blockingcrossspeciessecondarybindingwhenperformingdoubleimmunostainingwithmouseandratprimaryantibodies
AT noamacohen blockingcrossspeciessecondarybindingwhenperformingdoubleimmunostainingwithmouseandratprimaryantibodies
AT noamacohen blockingcrossspeciessecondarybindingwhenperformingdoubleimmunostainingwithmouseandratprimaryantibodies
AT akivascohen blockingcrossspeciessecondarybindingwhenperformingdoubleimmunostainingwithmouseandratprimaryantibodies
AT akivascohen blockingcrossspeciessecondarybindingwhenperformingdoubleimmunostainingwithmouseandratprimaryantibodies
_version_ 1721427971671064576